Is Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Timothy J. Scannell net worth and biography

Timothy Scannell Biography and Net Worth

Director of Insulet

Mr. Scannell has served on our Board of Directors since August 2014 and as our Board Chair since January 1, 2019. He also serves on the Board of Directors of Novocure, Renalytix and AeroClean Technologies. From October 2021 to March 2023, he served as an Executive Advisor at Stryker Corporation, one of the world's leading medical technology companies that offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. From August 2018 to September 2021, he served as the President and Chief Operating Officer at Stryker, and from 2009 to August 2018, he served as a Group President and oversaw Stryker’s MedSurg and Neurotechnology divisions. From 1990 to 2009, Mr. Scannell served in various roles at Stryker, including a range of sales and marketing leadership roles, Vice President and General Manager of its Biotech division and President of its Spine business. Mr. Scannell holds a Bachelor of Business Administration and a Master of Business Administration from the University of Notre Dame. He brings extensive strategic, organizational, and operational skills and experience.

What is Timothy J. Scannell's net worth?: The estimated net worth of Timothy J. Scannell is at least $9.49 million as of June 10th, 2024. Mr. Scannell owns 35,586 shares of Insulet stock worth more than $9,486,160 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Scannell may own. Learn More about Timothy J. Scannell's net worth.
How do I contact Timothy J. Scannell?: The corporate mailing address for Mr. Scannell and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at [email protected]. Learn More on Timothy J. Scannell's contact information.
Has Timothy J. Scannell been buying or selling shares of Insulet?: Timothy J. Scannell has not been actively trading shares of Insulet in the last ninety days. Most recently, Timothy J. Scannell sold 7,000 shares of the business's stock in a transaction on Monday, June 10th. The shares were sold at an average price of $190.51, for a transaction totalling $1,333,570.00. Following the completion of the sale, the director now directly owns 35,586 shares of the company's stock, valued at $6,779,488.86. Learn More on Timothy J. Scannell's trading history.
Who are Insulet's active insiders?: Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Bret Christensen (EVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), James Hollingshead (CEO), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.
Are insiders buying or selling shares of Insulet?: In the last twelve months, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 26,455 shares worth more than $4,779,816.91. The most recent insider tranaction occured on December, 10th when CAO Lauren Budden sold 915 shares worth more than $252,192.30. Insiders at Insulet own 0.5% of the company. Learn More about insider trades at Insulet.
Information on this page was last updated on 12/10/2024.

Timothy J. Scannell Insider Trading History at Insulet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/10/2024	Sell	7,000	$190.51	$1,333,570.00	35,586
5/28/2024	Sell	3,300	$180.90	$596,970.00	42,586
5/15/2015	Buy	3,500	$27.05	$94,675.00

Timothy J. Scannell Buying and Selling Activity at Insulet

Insulet Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Today's Range

Now: $266.57

$256.56

$270.70

50 Day Range

MA: $253.81

$229.13

$275.70

2 Week Range

Now: $266.57

$160.19

$279.77

Volume

1,465,981 shs

Average Volume

763,584 shs

Market Capitalization

$18.70 billion

P/E Ratio

45.65

Dividend Yield

N/A

Beta

1.21

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

Click here now for the urgent details.